Top 5 Takeaways Increased Protection with Boosters: Additional primary or booster COVID-19 vaccine doses significantly enhance protection against the Omicron variant in nursing home residents, showing a relative vaccine effectiveness

Top 5 Takeaways Decrease in West Nile Virus Incidence: The national incidence of neuroinvasive West Nile Virus (WNV) disease in 2020 was 59% lower than the median annual incidence from

Top 5 Takeaways Rabies Vaccination Recommendations Updated: A new 2-dose intramuscular rabies vaccination series on days 0 and 7 has replaced the previous 3-dose schedule, aimed at increasing adherence and

Top 5 Takeaways Increased Incidence: A significant rise in nontoxigenic Corynebacterium diphtheriae cases in Washington, with numbers increasing tenfold from 2012–2017 to 2018–2023. High-Risk Populations: Most cases occurred among residents

Top 5 Takeaways Increased Incidence of Post-COVID Conditions: Adults who survived COVID-19 are at a higher risk of developing conditions such as pulmonary embolism and respiratory symptoms, with 38% of

Top 5 Takeaways New Vaccination Recommendation: As of February 28, 2024, the Advisory Committee on Immunization Practices (ACIP) recommends an additional dose of the updated (2023–2024 Formula) COVID-19 vaccine for

Top 5 Takeaways Rapid Outbreak Following School Event: An outbreak of influenza A(H3N2) occurred among attendees of a school banquet, with 41% of students reporting symptoms within a median of

Top 5 Takeaways New Vaccine Approval: The FDA has approved the Pfizer Pentavalent Meningococcal Vaccine (MenACWY-TT/MenB-FHbp, branded as Penbraya) for individuals aged 10–25 years to protect against serogroups A, B,

Top 5 Takeaways High Infection and Hospitalization Rates: Throughout the study period, SARS-CoV-2 infection rates ranged from 61.4 to 133.8 per 10,000 nursing home residents, with a peak of 133.8